[HTML][HTML] Cardiovascular disease does not predict exacerbation rate or mortality in chronic obstructive pulmonary disease

PW Jones, H Mullerova, A Agusti… - American Journal of …, 2018 - atsjournals.org
Methods The ACCESS (Assessment of Comorbidities in COPD in European Symptomatic
Subjects) study (NCT01516528; GlaxoSmithKline study 115058) was a prospective …

[引用][C] Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease

PW Jones, H Mullerova, A Agusti… - … of respiratory and …, 2018 - pubmed.ncbi.nlm.nih.gov
Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive
Pulmonary Disease Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in …

Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease

PW Jones, MD Alvar Agusti… - American Journal of …, 2018 - search.proquest.com
Abstract To the Editor: Cardiovascular disease (CVD) is common in patients with chronic
obstructive pulmonary disease (COPD)(1-4), yet it is unclear whether its presence increases …

Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease.

PW Jones, H Mullerova, A Agusti… - Am J Respir Crit …, 2018 - openaccess.sgul.ac.uk
Methods The ACCESS study (Assessment of Comorbidities in COPD in European
Symptomatic Subjects; NCT01516528; 115058 study) was a prospective, longitudinal …

[引用][C] Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease.

PW Jones, H Mullerova, A Agusti… - American Journal of …, 2018 - europepmc.org
Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic
Obstructive Pulmonary Disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[PDF][PDF] CARDIOVASCULAR DISEASE DOES NOT PREDICT EXACERBATION RATE OR MORTALITY IN COPD

PW Jones, H Mullerova, A Agusti, M Decramer… - openaccess.sgul.ac.uk
Methods The ACCESS study (Assessment of Comorbidities in COPD in European
Symptomatic Subjects; NCT01516528; 115058 study) was a prospective, longitudinal …